Simvastatin Plus Rifaximin to Prevent ACLF in Patients with Decompensated Cirrhosis. A Randomised, Double-Blind, Placebo-Controlled, Phase-3 Trial: the Liverhope Efficacy Trial Elisa Pose , Cesar Jimenez , Giacomo Zaccherini , Daniela Campion , Salvatore Piano , Frank Erhard Uschner , Koos de Wit , Olivier Roux , Kohilan Gananandan , Wim Laleman , Cristina Sole , Sonia Alonso , Berta Cuyas , Xavier Ariza , Adria Juanola , Ann T. Ma , Laura Napoleone , Jordi Gratacos , Marta Tonon , Enrico Pompili , Jordi Sanchez-Delgado , Marta Carol , Martina Perez , Nuria Fabrellas , Judit Pich , Claudia Martell , Georgina Casanovas , Gemma Domenech , Ferran Torres , Victor Manuel , Vargas Blasco , Paolo Caraceni , Carlo Alessandria , Paolo Angeli , Jonel Trebicka , Ulrich Beuers , Claire Francoz , Raj Mookerjee , Rafael Banares , German Soriano , Ruben Hernaez , Andrew S. Allegretti , Manuel Morales-Ruiz , Miquel Serra , Hugh Watson , Juan G. Abraldes , Patrick S. Kamath , Pere Gines JOURNAL OF HEPATOLOGY（2023）
Key words
Liver Cirrhosis, Treatment
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
